Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 3, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tobey Sommer Maintained (CCRN) at Hold with Decreased Target to $22 on, Nov 3rd, 2023
Tobey Sommer of Truist Securities, Maintained "Cross Country Healthcare, Inc." (CCRN) at Hold with Decreased Target from $25 to $22 on, Nov 3rd, 2023.
Tobey has made no other calls on CCRN in the last 4 months.
There are 2 other peers that have a rating on CCRN. Out of the 2 peers that are also analyzing CCRN, 1 agrees with Tobey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
This is the rating of the analyst that currently disagrees with Tobey
- Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $29 on, Monday, August 14th, 2023
